Spiriva, Atrovent, and other COPD Drugs

Chronic obstructive pulmonary disease (COPD) drugs Spiriva® and Atrovent® have been linked to an increase risk of heart attack, stroke, and cardiovascular death.  A paper published in the Journal of the American Medical Association states that people taking Spiriva® or Atrovent® have a 58% increased of cardiac death, heart attack, or stroke.

The makers of Spiriva® deny that their drug causes an increased risk of heart attack, stroke, or cardiac death.  The U.S. Food and Drug Administration has issued an early communication warning of a possible increased risk of stroke for people taking Spiriva®.


We Can Help

If you or a loved one has suffered an adverse cardiac event, heart attack, stroke, or cardiac death while taking Spiriva®, Atrovent®, or any prescription drug for the treatment of COPD, contact The Law Offices of Larry H. Parker.  We are proud to be partnered with a nationally recognized team of product liability attorneys focused on obtaining the maximum recovery possible.  Our team of pharmaceutical attorneys is ready to fight for you!

For a free, confidential, no-obligation consultation, please fill out a form or give us a call at (800) 333-0000.  Your call or email will only be handled by caring, understanding, and experienced case evaluators.  Your confidentiality is guaranteed! Nobody will fight harder for you.  Nobody.

* Please be advised that no attorney/client relationship will be established by website visit or submission to larryhparker.com™. An attorney/client relationship can only begin when a retainer has been signed.